Department of Medicine

April 6, 2023

A ‘supermere’ method for biomarker discovery

Vanderbilt researchers have developed a method for isolating extracellular vesicles and nanoparticles — a complex transport system involved in health and disease — which will improve biomarker discovery and the identification of therapeutic targets.

By Bill Snyder
April 4, 2023

Vanderbilt receives $1 million in funding for electric vehicle research

Vanderbilt has received funding for two projects that will examine the benefits of and barriers to widespread use of electric vehicles and potential public health impacts of EV adoption.

By VUMC News and Communications
March 31, 2023

April 2023 Medicine Grand Rounds announced

By VUMC News and Communications
March 30, 2023

New treatment helps mitigate hair loss for chemotherapy patients

Vanderbilt-Ingram Cancer Center has started offering scalp cooling, which mitigates hair loss for patients receiving certain chemotherapy regimens.

By Tom Wilemon
VUMC employees will still be able to get vaccines or boosters at the Occupational Health Clinic at Suite 640 in the Medical Arts Building.
March 30, 2023

One Hundred Oaks COVID-19 vaccination site to close April 7

The COVID-19 vaccination site at Vanderbilt Health One Hundred Oaks will close on April 7.

By VUMC News and Communications
March 30, 2023

VUMC researcher selected for Global Scholars Program

Vanderbilt researcher P. Brent Ferrell, MD, is leading one of five projects selected by the 2022 Novartis Institutes for BioMedical Research Global Scholars Program.

By Leigh MacMillan
March 28, 2023

Inflammation implicated in exfoliation syndrome

Computational genetics tools have implicated inflammatory pathways in exfoliation syndrome, the most common cause of secondary glaucoma, which can result in blindness.
By Leigh MacMillan
March 23, 2023

Saunders receives diabetes research innovation award

Vanderbilt's Diane Saunders, PhD, has been selected as a 2023 recipient of an Innovation Award by the Network of Pancreatic Donors with Diabetes.
By Jill Clendening
March 16, 2023

Study evaluates polygenic risk score for prostate cancer risk prediction

A Vanderbilt study found that prostate cancer polygenic risk score has limited utility for enhancing prostate cancer screening.
By Leigh MacMillan
March 16, 2023

Eng stresses need for clinical trial support at cancer forum

Vanderbilt's Cathy Eng, MD, stressed the need for more patient participation and better funding for clinical trials to improve colorectal cancer treatment and outcomes during the White House Cancer Moonshot Colorectal Cancer Forum.
By Tom Wilemon
March 9, 2023

Study finds RSV may evade vaccines via rapid mutation

A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.
By Bill Snyder
March 6, 2023

Cell-free hemoglobin in pulmonary hypertension

Cell-free hemoglobin generated by the lungs may be a therapeutic target for treating pulmonary arterial hypertension, Vanderbilt researchers found.
By Leigh MacMillan
March 2, 2023

Sex-specific regulation of kidney signals

Links between estrogen signaling and sodium excretion by the kidney could help explain a reduced risk of hypertension in females versus males.
By Kelsey Pinckard
1 … 12 13 14 15 16 … 102